LCUK:F:F-Lyxor Core UK Equity All Cap (DR) UCITS ETF Dist (EUR)

ETF | Others |

Last Closing

USD 13.77

Change

-0.01 (-0.07)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-06 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.07 (+0.25%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.15 (+0.29%)

USD 116.19B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 109.51B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.16 (+0.28%)

USD 98.97B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.07 (+0.43%)

USD 63.27B
SXRZ:F iShares VII PLC - iShares Nikk..

+1.45 (+0.60%)

USD 52.42B
VUSA:F Vanguard Funds Public Limited ..

-0.77 (-0.70%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.02 (-0.23%)

USD 38.52B
0ZC:F Zscaler Inc

+3.40 (+1.90%)

USD 37.92B

ETFs Containing LCUK:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.81% 51% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.81% 51% F 41% F
Trailing 12 Months  
Capital Gain 10.89% 55% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.89% 51% F 50% F
Trailing 5 Years  
Capital Gain 6.50% 39% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.50% 38% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain 8.05% 63% D 61% D-
Dividend Return 8.05% 60% D- 54% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.85% 58% F 86% B+
Risk Adjusted Return 67.94% 71% C- 78% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike